Autopsy report · NCT07155980

A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants

“The protocol is being withdrawn prior to enrollment due to a redesign of the study approach under the existing IND.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Acta Pharmaceuticals

Sponsor type

Industry

Conditions

Healthy Adult Participants

Interventions

GSM-779690T; Placebo

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis
  “Study Withdrawn by Sponsor prior to Enrollment.” (72% match in meaning)
• Study of Inborn Errors of Cholesterol Synthesis and Related Disorders
  “Study terminated due to low enrollment and availability of alternative protocols.” (71% match in meaning)
• Characteristic Analysis and Surgical Exploration for Acetabular Roof Fractures: Multicenter Retrospective Cohort Study
  “Due to limited funding, the study is now being withdrawn.” (70% match in meaning)
• Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized COPD Patients
  “The study was withdrawn prior to initiation. The protocol was submitted for IRB review but was not approved. No participants were enrolled.” (70% match in meaning)
• Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
  “Withdrawn: study halted prematurely, prior to enrollment of first participant” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.